The PE Ratio as of December 2025 (TTM) for VistaGen Therapeutics, Inc. (VTGN) is -2.23

According to VistaGen Therapeutics, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -2.23. This represents a change of 56.30% compared to the average of -1.43 of the last 4 quarters.

VistaGen Therapeutics, Inc. (VTGN) Historical PE Ratio (quarterly & annually)

How has VTGN PE Ratio performed in the past?

The mean historical PE Ratio of VistaGen Therapeutics, Inc. over the last ten years is -2.60. The current -2.23 PE Ratio has changed 8.48% with respect to the historical average. Over the past ten years (40 quarters), VTGN's PE Ratio was at its highest in in the September 2022 quarter at -0.44. The PE Ratio was at its lowest in in the June 2021 quarter at -19.31.

VistaGen Therapeutics, Inc. (VTGN) PE Ratio by Quarter and Year

Discovering the peaks and valleys of VistaGen Therapeutics, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

VistaGen Therapeutics, Inc. (VTGN) Average PE Ratio

How has VTGN PE Ratio performed in the past?

The current PE Ratio of VistaGen Therapeutics, Inc. (VTGN) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

VistaGen Therapeutics, Inc. (VTGN) PE Ratio vs. Peers

How is VTGN’s PE Ratio compared to its peers?

VistaGen Therapeutics, Inc.’s PE Ratio is greater than Spero Therapeutics, Inc. (-2.93), less than Seer, Inc. (-1.36), less than Seres Therapeutics, Inc. (29.07), greater than Opus Genetics, Inc. (-2.43), greater than Cognition Therapeutics, Inc. (-3.40), less than TuHURA Biosciences, Inc. (-1.51), less than Agenus Inc. (-0.69), greater than Actuate Therapeutics Inc (-6.52), less than Acumen Pharmaceuticals, Inc. (-0.90), less than Inovio Pharmaceuticals, Inc. (-0.00),

Build a custom stock screener for VistaGen Therapeutics, Inc. (VTGN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like VistaGen Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

VistaGen Therapeutics, Inc. (VTGN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like VistaGen Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.